Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somatostatin for stress and inflammatory response in critically ill patients
ChiCTR-TRC-11001374Phase 4Recruiting
- Sponsor
- Suzhou Kowloon Hospital
- Start
- Dec 2010
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of somatostatin in Systemic Inflammatory Response Syndrome (SIRS) and critical illness (2 arms), sponsored by Suzhou Kowloon Hospital. Primary endpoint: clinical index. Started Dec 2010; status: recruiting.
02
Drugs
somatostatin
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)critical illness
Beyond the preview
Go deeper on ChiCTR-TRC-11001374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001374.